Patent · US Active

N-cyano-7-azanorbornane derivatives and uses thereof

US11572374B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

AMGEN INC. · US

Inventors

John R. BUTLER · Colton, US
Daniel Erlanson · San Francisco, US
Russell Graceffa · Hampton, US
Jeffrey Iwig · Albany, US
Joon Won Jeong · Belmont, US
Ryan White · Thousand Oaks, US
Yongwei Wu · Longbeilingcun, CN
Shuyan Yi · Malden, US
Xiao Mei Zheng · Natick, US
Jesse M. McFarland · Berkeley, US
Abhisek Banerjee · Narayanpur, IN

Key dates

Filing date	Aug 13, 2019
Grant date	Feb 7, 2023
Priority date	—
Expiry date	Aug 16, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.